No Detail Found!

End Treatment Response in Chronic Hepatitis CPatients to Sofosbuvir and Ribavirin

Author(s)
Valeed Bin Mansoor Rawalpindi Medical College, Rawalpindi, Pakistan
Usman Ahmed Rawalpindi Medical College, Rawalpindi, Pakistan
Muhammad Jahanzaib Rawalpindi Medical College, Rawalpindi, Pakistan
Zeeshan Ali Rawalpindi Medical College, Rawalpindi, Pakistan
Muhammad Asad Haroon Rawalpindi Medical College, Rawalpindi, Pakistan
Hanan Ahmed Rawalpindi Medical College, Rawalpindi, Pakistan
Abdul Munim Rawalpindi Medical College, Rawalpindi, Pakistan
Abstract
Objective: To investigate the end treatment response of Sofosbuvir and Ribavirin in chronic hepatitis C patients and determine the efficacy of this drug combination. Study Design: Retrospective study Place and Duration: September 15th 2015 and May 19th 2016 Materials and Methods: A total of 153 cases were taken who attended the hospital between September 15th 2015 and May 19th 2016 were included in this study and had their PCR done at 4 and 24 months. It comprises of both treatment naive (those who had not been treated previously for Hepatitis C) and treatment experienced (those who had previous treatment failure for hepatitis C or relapse, either due to the drug intolerance, drug resistance and/or other factors). SPSS v21 was used to analyze the data. Results: The end treatment response with aforementioned combination was calculated for 153 cases in which 96.07% responded to the therapy irrespective of their genotypes, type 3 being the most encountered in this study. There was no difference in treatment responses between males and females and p value came out > .05 Conclusion: Drug Combination's(Sofosbuvir and Ribavirin) efficacy was demonstrated in chronic hepatitis C patients. It was seen to be a very effective combination for the treatment compared to older regimens. Although this requires further studies to confirm the findings our study emphasize that this therapy should be made readily available.
Publication Details
Page(s) 127-130
DOI DOI not available
Published Journal: Annals of the Pakistan Institute of Medical Sciences, Volume: 12, Issue: 3, Year: 2016

Request the full text from PASTIC

Keywords
Sofosbuvir, Genotype, ribavirin, Sovaldi., Chronic hepatitis C
0

Citations

0

Downloads

70

Views